GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytophage Technologies Ltd (TSXV:CYTO) » Definitions » Issuance of Debt

Cytophage Technologies (TSXV:CYTO) Issuance of Debt : C$0.00 Mil (TTM As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Cytophage Technologies Issuance of Debt?

Cytophage Technologies's Issuance of Debt for the three months ended in Sep. 2024 was C$0.00 Mil.

Cytophage Technologies's Issuance of Debt for the trailing twelve months (TTM) ended in Sep. 2024 was C$0.00 Mil.

Cytophage Technologies Issuance of Debt Historical Data

The historical data trend for Cytophage Technologies's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytophage Technologies Issuance of Debt Chart

Cytophage Technologies Annual Data
Trend Dec21 Dec22 Dec23
Issuance of Debt
- - -

Cytophage Technologies Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Cytophage Technologies Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cytophage Technologies Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Cytophage Technologies's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Cytophage Technologies Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytophage Technologies Ltd (TSXV:CYTO) » Definitions » Issuance of Debt
Comparable Companies
TSXV:IBO TSXV:RKV TSXV:IOT XCNQ:GLOW XCNQ:LOBE XCNQ:ASEP TSXV:MRVL TSXV:QPT TSX:APLI XCNQ:RIZE VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
26 Henlow Bay, Winnipeg, MB, CAN, R3Y 1G4
Website
https://www.cytophage.com
Cytophage Technologies Ltd is a Canadian biotechnology company that uses molecular genetic techniques and synthetic biology to create effective bacteriophages to address bacterial challenges affecting animal health, human health, and food security. Bacteriophages are viruses that have evolved to specifically target and destroy strictly bacterial cells and are safe for humans, animals, and plants. To combat dangerous bacteria company generates phages to address specific bacterial infections, including strains resistant to antibiotics. It has also developed a 'phage-display' methodology to develop vaccine-like products using bacteriophages for a number of potential applications in human and animal health.

Cytophage Technologies Headlines

No Headlines